BR0015398A - Vacinas para mycoplasma bovis e processos de uso - Google Patents
Vacinas para mycoplasma bovis e processos de usoInfo
- Publication number
- BR0015398A BR0015398A BR0015398-2A BR0015398A BR0015398A BR 0015398 A BR0015398 A BR 0015398A BR 0015398 A BR0015398 A BR 0015398A BR 0015398 A BR0015398 A BR 0015398A
- Authority
- BR
- Brazil
- Prior art keywords
- vaccines
- bovis
- infections
- processes
- mycoplasma
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 7
- 241000283690 Bos taurus Species 0.000 title abstract 2
- 241000204031 Mycoplasma Species 0.000 title 1
- 241001138504 Mycoplasma bovis Species 0.000 abstract 6
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 206010060968 Arthritis infective Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010033078 Otitis media Diseases 0.000 abstract 1
- 206010035664 Pneumonia Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 230000009851 immunogenic response Effects 0.000 abstract 1
- 208000022760 infectious otitis media Diseases 0.000 abstract 1
- 206010023332 keratitis Diseases 0.000 abstract 1
- 201000010666 keratoconjunctivitis Diseases 0.000 abstract 1
- 208000004396 mastitis Diseases 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 230000004584 weight gain Effects 0.000 abstract 1
- 235000019786 weight gain Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16428699P | 1999-11-08 | 1999-11-08 | |
| PCT/US2000/042000 WO2001034189A2 (en) | 1999-11-08 | 2000-11-08 | Vaccines for mycoplasma bovis and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0015398A true BR0015398A (pt) | 2002-06-25 |
Family
ID=22593810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0015398-2A BR0015398A (pt) | 1999-11-08 | 2000-11-08 | Vacinas para mycoplasma bovis e processos de uso |
Country Status (10)
| Country | Link |
|---|---|
| US (7) | US7943153B1 (enExample) |
| EP (1) | EP1229929A2 (enExample) |
| JP (1) | JP2003513935A (enExample) |
| AU (1) | AU782508B2 (enExample) |
| BR (1) | BR0015398A (enExample) |
| CA (1) | CA2390613A1 (enExample) |
| IL (1) | IL149471A0 (enExample) |
| MX (1) | MXPA02004627A (enExample) |
| WO (1) | WO2001034189A2 (enExample) |
| ZA (1) | ZA200203622B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2390613A1 (en) * | 1999-11-08 | 2001-05-17 | Biomune | Vaccines for mycoplasma bovis and methods of use |
| GB0110851D0 (en) * | 2001-05-03 | 2001-06-27 | Mini Agriculture & Fisheries | Vaccine |
| US20030147914A1 (en) * | 2001-07-02 | 2003-08-07 | Pfizer Inc. | Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
| BR0211563A (pt) * | 2001-08-28 | 2004-07-13 | Pfizer Prod Inc | Modelo de infecção por mycoplasma bovis e métodos para administração de m. bovis e para indução de lesões pneumÈnicas do pulmão |
| US20110059437A1 (en) * | 2006-09-07 | 2011-03-10 | Boehringer Ingelheim Vetmedica, Inc. | Pcr-based genotyping |
| CL2008003202A1 (es) | 2007-10-29 | 2009-11-27 | Boehringer Ingelheim Vetmedica Inc | Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta. |
| US9056909B2 (en) * | 2007-11-06 | 2015-06-16 | Zoetis Services Llc | Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine |
| EP2163239A1 (de) * | 2008-05-27 | 2010-03-17 | Qiagen GmbH | Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung |
| EP2320943B1 (en) * | 2008-07-03 | 2016-02-17 | Iowa State University Research Foundation, Inc. | Cattle vaccines |
| SG10201506597RA (en) | 2008-10-31 | 2015-10-29 | Boehringer Ingelheim Vetmed | Use Of Various Antigens Including Antigens From Mycoplasma Bovis In Multivalent Vaccine Composition |
| UY32570A (es) * | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
| WO2010140377A1 (ja) | 2009-06-04 | 2010-12-09 | 独立行政法人産業技術総合研究所 | マイコプラズマ感染症用ワクチン |
| WO2011044576A2 (en) | 2009-10-09 | 2011-04-14 | Children's Medical Center Corporation | Selectively disrupted whole-cell vaccine |
| EP2621951A1 (en) * | 2010-09-29 | 2013-08-07 | Université de Liège | Combination of an agonistic anti-cd40 monoclonal antibody or a cd40 ligand and inactivated or attenuated bacteria for use in the treatment and/or prevention of mastitis |
| US9052315B2 (en) | 2012-05-09 | 2015-06-09 | Advanced Animal Diagnostics, Inc. | Rapid detection of analytes in liquid samples |
| US10359614B2 (en) | 2012-07-03 | 2019-07-23 | Advanced Animal Diagnostics, Inc. | Diagnostic apparatus |
| HUE059179T2 (hu) | 2012-09-10 | 2022-10-28 | Galenbio Inc | Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag |
| US9797893B2 (en) | 2013-05-09 | 2017-10-24 | Advanced Animal Diagnostics, Inc. | Rapid detection of analytes in liquid samples |
| DK3334454T3 (da) | 2015-08-14 | 2022-11-14 | Zoetis Services Llc | Mycoplasma-Bovis-sammensætninger |
| CN110338138B (zh) * | 2019-06-19 | 2021-04-06 | 山东省农业科学院奶牛研究中心 | 一种牛支原体感染豚鼠的动物模型构建方法及其应用 |
| CN113040094B (zh) * | 2021-03-18 | 2022-06-21 | 中国农业大学 | 一种牛支原体性小鼠乳腺炎模型的构建方法及其应用 |
| CN116751723A (zh) * | 2023-07-24 | 2023-09-15 | 吉林农业大学 | 一种牛支原体菌株及其灭活疫苗和应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0043272B1 (en) | 1980-07-01 | 1984-06-13 | National Research Development Corporation | Production of viral antigens |
| US4425330A (en) * | 1981-05-20 | 1984-01-10 | Cornell Research Foundation, Inc. | Bovine mastitis vaccine and method for detecting efficacy thereof |
| US4517394A (en) * | 1983-07-05 | 1985-05-14 | W. R. Grace & Co. | Preparation of nitro compounds by vapor phase nitration of carboxylic acids |
| US5178860A (en) | 1989-09-01 | 1993-01-12 | Coopers Animal Health Limited | Adjuvant complexes and vaccine made therefrom |
| US4981684A (en) | 1989-10-24 | 1991-01-01 | Coopers Animal Health Limited | Formation of adjuvant complexes |
| US5565205A (en) | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
| CA2057946A1 (en) * | 1990-12-20 | 1992-06-21 | Michael M. Thackeray | Electrochemical cell |
| US5316875A (en) * | 1991-07-19 | 1994-05-31 | Matsushita Electric Industrial Co., Ltd. | Secondary battery with nonaqueous electrolyte and method of manufacturing same |
| US5338543A (en) | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
| US5585098A (en) | 1993-11-23 | 1996-12-17 | Ovimmune, Inc. | Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants |
| DK0744937T3 (da) * | 1994-02-18 | 2002-10-28 | Solidose L L C | Vaccination af dyr med tørrede, pelleterede biologiske materialer |
| JP3702353B2 (ja) * | 1996-05-24 | 2005-10-05 | 日本電池株式会社 | リチウム電池用正極活物質の製造方法およびリチウム電池 |
| CA2390613A1 (en) * | 1999-11-08 | 2001-05-17 | Biomune | Vaccines for mycoplasma bovis and methods of use |
| DE29921392U1 (de) | 1999-12-06 | 2000-03-16 | Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben | Mykoplasma-bovis-Kombinations-Vakzine für Rinder |
| US6677082B2 (en) * | 2000-06-22 | 2004-01-13 | The University Of Chicago | Lithium metal oxide electrodes for lithium cells and batteries |
| US6680143B2 (en) * | 2000-06-22 | 2004-01-20 | The University Of Chicago | Lithium metal oxide electrodes for lithium cells and batteries |
| JP3500424B2 (ja) * | 2000-08-31 | 2004-02-23 | 独立行政法人産業技術総合研究所 | 単相リチウムフェライト系複合酸化物 |
| US6548069B2 (en) | 2001-02-03 | 2003-04-15 | Hmv Associates, Inc. | Multivalent Mycoplasma bacterin |
-
2000
- 2000-11-08 CA CA002390613A patent/CA2390613A1/en not_active Abandoned
- 2000-11-08 IL IL14947100A patent/IL149471A0/xx unknown
- 2000-11-08 MX MXPA02004627A patent/MXPA02004627A/es not_active Application Discontinuation
- 2000-11-08 BR BR0015398-2A patent/BR0015398A/pt not_active Application Discontinuation
- 2000-11-08 EP EP00989763A patent/EP1229929A2/en not_active Withdrawn
- 2000-11-08 US US09/708,352 patent/US7943153B1/en not_active Expired - Fee Related
- 2000-11-08 WO PCT/US2000/042000 patent/WO2001034189A2/en not_active Ceased
- 2000-11-08 AU AU26225/01A patent/AU782508B2/en not_active Ceased
- 2000-11-08 JP JP2001536186A patent/JP2003513935A/ja active Pending
-
2002
- 2002-05-07 ZA ZA200203622A patent/ZA200203622B/en unknown
-
2003
- 2003-12-01 US US10/726,029 patent/US7429389B2/en not_active Expired - Fee Related
-
2004
- 2004-04-14 US US10/825,391 patent/US7416734B2/en not_active Expired - Fee Related
-
2006
- 2006-07-18 US US11/489,147 patent/US20070077260A1/en not_active Abandoned
-
2007
- 2007-10-31 US US11/982,079 patent/US20090220550A1/en not_active Abandoned
- 2007-10-31 US US11/982,265 patent/US20080226671A1/en not_active Abandoned
- 2007-10-31 US US11/982,082 patent/US20090263427A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003513935A (ja) | 2003-04-15 |
| US20090263427A1 (en) | 2009-10-22 |
| US20070077260A1 (en) | 2007-04-05 |
| US20050118200A1 (en) | 2005-06-02 |
| AU782508B2 (en) | 2005-08-04 |
| IL149471A0 (en) | 2002-11-10 |
| US7429389B2 (en) | 2008-09-30 |
| US20050053627A1 (en) | 2005-03-10 |
| US20080226671A1 (en) | 2008-09-18 |
| US20090220550A1 (en) | 2009-09-03 |
| AU2622501A (en) | 2001-06-06 |
| US7943153B1 (en) | 2011-05-17 |
| US20080069842A9 (en) | 2008-03-20 |
| US7416734B2 (en) | 2008-08-26 |
| WO2001034189A2 (en) | 2001-05-17 |
| CA2390613A1 (en) | 2001-05-17 |
| MXPA02004627A (es) | 2004-02-18 |
| WO2001034189A3 (en) | 2001-12-27 |
| ZA200203622B (en) | 2003-07-30 |
| EP1229929A2 (en) | 2002-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02004627A (es) | Vacunas contra el micoplasma bovis y sus metodos de uso. | |
| BR0111366A (pt) | Vacina de poxvìrus recombinante do vìrus da sìndrome respiratória e reprodutiva de porcino (prrsv) | |
| ATE358722T1 (de) | Kälte-adaptierte pferde influenza-viren | |
| PT777490E (pt) | Enterotoxina mutante eficaz como adjuvante oral nao toxico | |
| MY199150A (en) | Nutritional composition | |
| WO2001060849A3 (en) | Cold-adapted equine influenza viruses | |
| JP2003513935A5 (enExample) | ||
| BR112021008646A2 (pt) | uma vacina para proteção contra streptococcus suis | |
| EP3549600A1 (en) | A vaccine for protection against streptococcus suis | |
| EP4349367A2 (en) | A vaccine for protection against streptococcus suis | |
| CA2931139C (en) | Swine vaccine against prrs and lawsonia intracellularis | |
| AU4930001A (en) | Cold-adapted equine influenza viruses | |
| HUP9700975A2 (hu) | Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok | |
| RU94028204A (ru) | Препарат "уберсан" для лечения мастита у сельскохозяйственных животных | |
| DE69033503D1 (de) | Nukleotidsequenzen und polypeptide von pestivirus, im einzelnen vom schweine-cholera-virus | |
| JP2021506777A (ja) | レンサ球菌感染防御のためのワクチン | |
| JP3109886B2 (ja) | 経鼻接種用ワクチン | |
| Blackmore et al. | Alternative strategies for the control of leptospirosis in dairy herds | |
| BR0212279A (pt) | Vacina obtida de linhagem celular para vìrus causador de anemia em galinhas | |
| BRPI0416178A (pt) | método de incorporação de antìgeno em vesìculas de membrana externa de bactérias neisseria e formulações de vacina resultantes | |
| BR9815953A (pt) | Vacinas contra infecção provocada por escherichia coli o157 | |
| BR9814556A (pt) | Cepas isoladas de staphylococcus aureus e vacinas fabricadas a partir das mesmas | |
| Martin | Respiratory Diseases in Cattle: A Seminar in the EEC Programme of Coordination of Research on Beef Production Held at Edinburgh, November 8–10, 1977 | |
| Ndereba et al. | Effective and health ways of minimizing eruption of COVİD-19 | |
| Ryan | Rinderpest: a continuing threat to livestock |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11 E 13 DA LPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |